Key Genomics

Key Genomics is a precision medicine company specializing in advanced genomic analysis and bioinformatics solutions. The company leverages next-generation sequencing (NGS) and proprietary algorithms to provide diagnostic services, particularly in the fields of oncology and rare diseases. Their core offerings include comprehensive tumor profiling and liquid biopsy tests that enable clinicians to identify actionable genetic mutations and monitor treatment response in real-time. Key Genomics aims to bridge the gap between complex genomic data and clinical decision-making to improve patient outcomes through personalized medicine. The company operates with a focus on high-throughput sequencing and data-driven insights to support both clinical diagnostics and pharmaceutical research. By integrating multi-omic data, Key Genomics provides a comprehensive view of the molecular drivers of disease.